CN Patent
CN114174270B — 吡嗪-2(1h)-酮类化合物的a晶型和b晶型及其制备方法
Assigned to Zhangzhou Pientzehuang Pharmaceutical Co Ltd · Expires 2023-06-06 · 3y expired
What this patent protects
一种吡嗪‑2(1H)‑酮类化合物的晶型及其制备方法,具体公开了式(ⅠI)化合物及其晶型的制备方法。
USPTO Abstract
一种吡嗪‑2(1H)‑酮类化合物的晶型及其制备方法,具体公开了式(ⅠI)化合物及其晶型的制备方法。
Drugs covered by this patent
- Pemazyre (PEMIGATINIB) · Incyte Corp
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.